Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$744M |
| 2 |
Baker Hughes
BKR
|
+$156M |
| 3 |
Walt Disney
DIS
|
+$130M |
| 4 |
Meta Platforms (Facebook)
META
|
+$124M |
| 5 |
Apple
AAPL
|
+$117M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$658M |
| 2 |
RAI
Reynolds American Inc
RAI
|
+$502M |
| 3 |
BHI
Baker Hughes
BHI
|
+$236M |
| 4 |
WFM
Whole Foods Market Inc
WFM
|
+$155M |
| 5 |
SPLS
Staples Inc
SPLS
|
+$73.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.32% |
| 2 | Financials | 16.15% |
| 3 | Healthcare | 13.87% |
| 4 | Industrials | 10.5% |
| 5 | Consumer Discretionary | 9.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Atlassian
TEAM
$26.3B
| $6.34M | ﹤0.01% |
180,257
+23,665
| +15% | +$841K |
|
|
ALDR
2027
DELISTED
Alder Biopharmaceuticals
ALDR
| $6.32M | ﹤0.01% |
515,986
+99,093
| +24% | +$1.03M |
|
2028
Golar LNG
GLNG
$5B
| $6.32M | ﹤0.01% |
279,352
+17,570
| +7% | +$386K |
|
|
DCOM
2029
DELISTED
Dime Community Bancshares
DCOM
| $6.32M | ﹤0.01% |
293,742
-45,704
| -13% | -$901K |
|
|
LION
2030
DELISTED
Fidelity Southern Corporation
LION
| $6.29M | ﹤0.01% |
266,318
+4,824
| +2% | +$107K |
|
|
SNR
2031
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
| $6.29M | ﹤0.01% |
687,450
+38,874
| +6% | +$373K |
|
2032
Hyster-Yale Materials Handling
HY
$628M
| $6.28M | ﹤0.01% |
82,213
+4,739
| +6% | +$333K |
|
2033
Infosys
INFY
$49.6B
| $6.28M | ﹤0.01% |
867,706
+22,012
| +3% | +$167K |
|
|
FBC
2034
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $6.26M | ﹤0.01% |
176,560
+4,027
| +2% | +$130K |
|
|
AVP
2035
DELISTED
Avon Products, Inc.
AVP
| $6.23M | ﹤0.01% |
2,673,835
+67,620
| +3% | +$200K |
|
|
CIVI
2036
DELISTED
Civitas Resources
CIVI
| $6.21M | ﹤0.01% |
188,280
+147,029
| +356% | +$4.19M |
|
|
ORBC
2037
DELISTED
ORBCOMM, Inc.
ORBC
| $6.19M | ﹤0.01% |
591,102
+24,854
| +4% | +$275K |
|
2038
Camden National
CAC
$1B
| $6.19M | ﹤0.01% |
141,770
+7,187
| +5% | +$294K |
|
2039
AtriCure
ATRC
$1.97B
| $6.17M | ﹤0.01% |
275,825
+9,575
| +4% | +$216K |
|
|
AIMT
2040
DELISTED
Aimmune Therapeutics
AIMT
| $6.14M | ﹤0.01% |
247,773
+8,079
| +3% | +$174K |
|
2041
CTS Corp
CTS
$1.86B
| $6.14M | ﹤0.01% |
254,613
+6,644
| +3% | +$149K |
|
2042
Cytokinetics
CYTK
$10.4B
| $6.12M | ﹤0.01% |
421,735
-26,541
| -6% | -$363K |
|
2043
Perdoceo Education
PRDO
$2.04B
| $6.11M | ﹤0.01% |
588,382
+15,522
| +3% | +$144K |
|
2044
Flex
FLEX
$43.4B
| $6.11M | ﹤0.01% |
493,028
-24,185
| -5% | -$298K |
|
2045
US Physical Therapy
USPH
$1.18B
| $6.1M | ﹤0.01% |
99,291
+5,445
| +6% | +$332K |
|
|
CONN
2046
DELISTED
Conn's Inc.
CONN
| $6.1M | ﹤0.01% |
216,712
+12,469
| +6% | +$261K |
|
|
CSR
2047
Centerspace
CSR
$932M
| $6.09M | ﹤0.01% |
99,765
+1,998
| +2% | +$122K |
|
|
AABA
2048
DELISTED
Altaba Inc
AABA
| $6.05M | ﹤0.01% |
91,313
+8,827
| +11% | +$542K |
|
2049
Ovintiv
OVV
$17.1B
| $6.04M | ﹤0.01% |
103,608
+4,125
| +4% | +$202K |
|
|
ANH
2050
DELISTED
Anworth Mortgage Asset Corporation
ANH
| $6.02M | ﹤0.01% |
1,001,736
+16,397
| +2% | +$99.4K |
|
Similar funds
Geode Capital Management's Q3 2017 Portfolio in Review
As of Q3 2017, Geode Capital Management held 4,158 positions worth $271B, up 6.5% from $254B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q3 2017: portfolio turnover was 4.7%. Geode Capital Management opened 87 new positions and exited 109, leaving the 4,158-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2017 buy was Baker Hughes: 4,388,225 shares worth $160M.
- Geode Capital Management added most to DuPont de Nemours in Q3 2017, an estimated $744M increase.
- Geode Capital Management's biggest Q3 2017 reduction was Hewlett Packard, cutting an estimated $61.7M.
- Geode Capital Management fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $658M.
- Geode Capital Management's ten largest holdings make up 16% of its $271B portfolio in Q3 2017.
- Geode Capital Management opened 87 new positions and closed 109 in Q3 2017.
- Geode Capital Management's portfolio value rose 6.5% quarter-over-quarter to $271B.
Based on Geode Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.